JP2025500459A5 - - Google Patents
Info
- Publication number
- JP2025500459A5 JP2025500459A5 JP2024538134A JP2024538134A JP2025500459A5 JP 2025500459 A5 JP2025500459 A5 JP 2025500459A5 JP 2024538134 A JP2024538134 A JP 2024538134A JP 2024538134 A JP2024538134 A JP 2024538134A JP 2025500459 A5 JP2025500459 A5 JP 2025500459A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- compound
- pharmaceutical composition
- intranasal
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2118559.0A GB2613900B (en) | 2021-12-20 | 2021-12-20 | Novel compounds and methods of use thereof |
| GB2118559.0 | 2021-12-20 | ||
| PCT/GB2022/053318 WO2023118846A1 (en) | 2021-12-20 | 2022-12-20 | Novel analogs of valproic acid and methods of medical treatment using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500459A JP2025500459A (ja) | 2025-01-09 |
| JP2025500459A5 true JP2025500459A5 (https=) | 2025-11-26 |
Family
ID=84887257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538134A Pending JP2025500459A (ja) | 2021-12-20 | 2022-12-20 | バルプロ酸の新規類似体及びそれを用いた治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250066282A1 (https=) |
| EP (1) | EP4452917A1 (https=) |
| JP (1) | JP2025500459A (https=) |
| KR (1) | KR20240152301A (https=) |
| CN (1) | CN118613464A (https=) |
| AU (1) | AU2022422574A1 (https=) |
| CA (1) | CA3242987A1 (https=) |
| GB (1) | GB2613900B (https=) |
| IL (1) | IL313669A (https=) |
| MX (1) | MX2024007654A (https=) |
| WO (1) | WO2023118846A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026068561A1 (en) | 2024-09-24 | 2026-04-02 | Cereno Scientific Ab | Valproic acid for use in treating pulmonary arterial hypertension |
| GB2644610A (en) * | 2024-09-27 | 2026-04-22 | Cereno Scient Ab | New methods |
| GB2644641A (en) * | 2024-09-24 | 2026-04-29 | Cereno Scient Ab | New methods |
| WO2026068552A1 (en) | 2024-09-24 | 2026-04-02 | Cereno Scientific Ab | Deuterated valproic acid compounds for use in treating pulmonary arterial hypertension |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120071554A1 (en) | 2008-10-28 | 2012-03-22 | Liu Julie F | Deuterated 2-propylpentanoic acid compounds |
| US20100143507A1 (en) * | 2008-12-09 | 2010-06-10 | Auspex Pharmaceuticals, Inc. | Carboxylic acid inhibitors of histone deacetylase, gaba transaminase and sodium channel |
| GB201417828D0 (en) * | 2014-10-08 | 2014-11-19 | Cereno Scient Ab | New methods and compositions |
| CA3018043A1 (en) * | 2016-04-08 | 2017-10-12 | Cereno Scientific Ab | Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof |
-
2021
- 2021-12-20 GB GB2118559.0A patent/GB2613900B/en active Active
-
2022
- 2022-12-20 KR KR1020247024372A patent/KR20240152301A/ko active Pending
- 2022-12-20 CN CN202280084449.3A patent/CN118613464A/zh active Pending
- 2022-12-20 WO PCT/GB2022/053318 patent/WO2023118846A1/en not_active Ceased
- 2022-12-20 JP JP2024538134A patent/JP2025500459A/ja active Pending
- 2022-12-20 MX MX2024007654A patent/MX2024007654A/es unknown
- 2022-12-20 AU AU2022422574A patent/AU2022422574A1/en active Pending
- 2022-12-20 EP EP22839416.9A patent/EP4452917A1/en active Pending
- 2022-12-20 US US18/721,594 patent/US20250066282A1/en active Pending
- 2022-12-20 IL IL313669A patent/IL313669A/en unknown
- 2022-12-20 CA CA3242987A patent/CA3242987A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025500459A5 (https=) | ||
| JP2025090726A5 (https=) | ||
| JP2018506563A5 (https=) | ||
| Muldoon et al. | Comparison between extradural infusion of ropivacaine or bupivacaine for the prevention of postoperative pain after total knee arthroplasty. | |
| JP2017504642A5 (https=) | ||
| Nishikawa et al. | Attenuation of the pressor response to laryngoscopy and tracheal intubation with intravenous verapamil | |
| JP2015524443A5 (https=) | ||
| RU96123712A (ru) | Пиразоло- и пирролопиридины | |
| JP2016511260A5 (https=) | ||
| JP2020522567A5 (https=) | ||
| JP2019528279A5 (https=) | ||
| JP2019131544A5 (https=) | ||
| JP2022545158A5 (https=) | ||
| Mather et al. | The effects of adding adrenaline to etidocaine and lignocaine in extradural anaesthesia II: Pharmacokinetics | |
| RU2019116820A (ru) | Антагонисты интегрина | |
| JP2018525371A5 (https=) | ||
| Milne et al. | The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man | |
| RU2024119718A (ru) | Новые аналоги вальпроевой кислоты и способы медикаментозного лечения с их применением | |
| JP2019507167A5 (https=) | ||
| MX2022010950A (es) | Compuesto triciclico fusionado y uso farmaceutico del mismo. | |
| Schweitzer et al. | The effect of atropine on cardiac arrhythmias and conduction. Part 1 | |
| 土手慶五 et al. | E fë: fºj stunning ž-E. | |
| JPWO2023032940A5 (https=) | ||
| RU2004136583A (ru) | Применение валсартана или его метаболита для ингибирования агрегации тромбоцитов | |
| FI4138881T3 (fi) | Koostumus, joka käsittää dnaasi i:n käytettäväksi menetelmässä, jolla estetään aim2-inflammasomin aktivaatio |